February 14, 2025 February 14, 2025Categories News StoriesFrom the group co-chairs of ECOG-ACRIN: A perspective on indirect costs (requires subscription)
February 6, 2025 February 6, 2025Categories News Stories“I was delighted when I saw the results. Positive phase 3 trials in glioma are a rarity.” David Schiff on the results of E3F05
January 17, 2025 January 17, 2025Categories Announcements News StoriesThe Winter 2025 advocacy blog Considering Clinical Trials is now available
January 16, 2025 January 16, 2025Categories News StoriesMajor breast cancer screening trial hits enrollment goal (features TMIST)
January 16, 2025 January 16, 2025Categories News StoriesTMIST breast cancer screening trial reaches enrollment milestone, advancing precision screening techniques
January 14, 2025 January 14, 2025Categories News StoriesCellular therapies and novel targeted agents will shape the future of acute lymphoblastic leukemia management (mentions E1910)
January 10, 2025 January 10, 2025Categories News StoriesAdjuvant tamoxifen reduces 15-year risk of recurrence in ‘good risk’ DCIS without radiation therapy (mentions E5194)
January 8, 2025 January 8, 2025Categories News StoriesWATCH: A recent FDA approval of blinatumomab was supported by data from the E1910 trial
